Stay updated on Ruxolitinib in COVID Cytokine Storm Clinical Trial
Sign up to get notified when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FIca0Eep_T-nZKMJbQa9NRgX8BIE.uncropped.jpg&w=3840&q=75)
Latest updates to the Ruxolitinib in COVID Cytokine Storm Clinical Trial page
- CheckyesterdayChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.1%
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check30 days agoNo Change Detected
- Check44 days agoChange DetectedThe study has expanded to include 61 locations, and the website has been updated to Revision v2.10.0, replacing the previous Revision v2.9.7.SummaryDifference0.3%
- Check51 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check62 days agoChange DetectedA new study on the use of Ruxolitinib in addition to standard care for COVID-19 treatment has been published in Lancet Rheumatology, with an erratum issued in 2024.SummaryDifference0.1%
- Check65 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.SummaryDifference0.1%
Stay in the know with updates to Ruxolitinib in COVID Cytokine Storm Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.